Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Effects of GLP-1 on Renal Hemodynamics
NCT04337268Phase 1Completed
- Sponsor
- Rigshospitalet
- Start
- Apr 2019
- Primary completion
- Mar 2020
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing GLP-1 Sequence with Placebo Sequence (2 arms). Primary endpoints: T2* signal at 1 hour, Arterial Spin Labeled at 1 hour and 1 more. Started Apr 2019; status: completed.
02
Drugs
Glucagon-like peptide 1
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04337268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04337268.